Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management of transient ischemic attack.

Padmavathy N Sylaja1, Michael D Hill

  • 1Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|March 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Confirmatory Study of Time-Dependent Computed Tomographic Perfusion Thresholds for Use in Acute Ischemic Stroke.

Stroke·2019
Same author

Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.

JAMA neurology·2019
Same author

Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke?

Stroke·2019
Same author

Distribution and current problems of acute endovascular therapy for large artery occlusion from a two-year national survey in Japan.

International journal of stroke : official journal of the International Stroke Society·2019
Same author

New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhage.

Neurology·2019
Same author

Endovascular treatment decision in acute stroke: does physician gender matter? Insights from UNMASK EVT, an international, multidisciplinary survey.

Journal of neurointerventional surgery·2019
Same journal

GLP-1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Across Myocardial Infarction-Defined Populations: A Systematic Review and Meta-Analysis.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same journal

Clinical Pharmacology of Plozasiran.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same journal

De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same journal

Correction: Impact of Aspirin on Primary Prevention of Cardiovascular Events in Patients with Elevated Lipoprotein(a): A Systematic Review and Meta-analysis.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same journal

Comment on "Polypill Strategy: A Paradigm Shift in Cardiovascular Disease Prevention".

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
Same journal

Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD?

American journal of cardiovascular drugs : drugs, devices, and other interventions·2026
See all related articles

Transient ischemic attack (TIA) precedes stroke, with many patients showing lesions on MRI. Identifying and treating high-risk TIA patients promptly is crucial for preventing major strokes.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Neuroimaging

Background:

  • Transient ischemic attack (TIA) is a critical warning sign for ischemic stroke.
  • A significant proportion of TIA patients exhibit new ischemic lesions on diffusion-weighted MRI.
  • The risk of stroke following TIA is substantial, particularly within the initial weeks.

Purpose of the Study:

  • To highlight the need for defined strategies to identify and manage high-risk TIA patients.
  • To address the uncertainty surrounding optimal medical and surgical interventions for TIA.
  • To emphasize the importance of timely treatment following TIA.

Main Methods:

  • Review of current medical literature and clinical guidelines regarding TIA management.
  • Analysis of diagnostic utility of diffusion-weighted magnetic resonance imaging (DWI) in TIA.

Related Experiment Videos

  • Evaluation of evidence for antiplatelet therapies and revascularization procedures.

    • Main Results:

    • Diffusion-weighted MRI frequently detects acute ischemic lesions in TIA patients.
    • A significant stroke risk (10-20%) exists within 3 months post-TIA, concentrated in the first week.
    • Aspirin is a primary treatment; clopidogrel and aspirin/dipyridamole combinations are alternatives.
    • Carotid endarterectomy or stenting benefits TIA patients with extracranial carotid artery stenosis.

    Conclusions:

    • Prompt identification and intervention are essential for high-risk TIA patients.
    • Optimal treatment timing and modality require further definition.
    • Established treatments include antiplatelet agents and revascularization for specific TIA etiologies.